Purdue's Motion To Dismiss Opioid Marketing Case Rejected

Introduction

Merrimack County Superior Court Judge John Kissinger rejected Purdue Pharma's motion to dismiss claims filed against it over opioid’s deceptive marketing in New Hampshire.

The county judge asserted that Purdue Pharma purposely downplayed the health risks of its opioid OxyContin and extensively marketed its benefits. The jury found the state's claims against the opioid manufacturer were not preempted by federal law, and they must face the trial to deal with opioid addiction accusations. Recently, Endo Pharmaceuticals announced to settle all opioid lawsuits filed against them in a separate track from the federal MDL.

More than 400 lawsuits associated with opioid injuries are centralized as a part of multidistrict litigation, MDL No. 2804 (In Re: National Prescription Opiate Litigation) in the Northern District of Ohio before U.S. District Judge Dan A. Polster. The first bellwether trial in the litigation has been scheduled for September 3, 2019.

Comments

First Federal Bellwether Trial Set in Strattice Mesh Case

Categories: Hernia Mesh

Lawyers involved in federal Strattice hernia mesh litigation are scheduled to meet with the presiding judge in the U.S. District Court for the District of New Jersey to…

Tepezza Hearing Loss Trial Set for June 2026

Categories: Tepezza

The U.S. District Judge overseeing all federal Tepezza lawsuits has postponed the start of the first bellwether trial by 60 days.

This decision comes as attorneys…

FDA Moves to Restrict Dangerous 7-OH Opioid Products

Categories: Opioids

In a significant move to combat the ongoing opioid crisis, the U.S. Food and Drug Administration (FDA) has recommended a scheduling action under the Controlled Substances Act (CSA) to regulate certain products containing 7-hydroxymitragynine (7-…

Purdue's Motion To Dismiss Opioid Marketing Case Rejected